What to Expect During a Lung Cancer Screening

But because lung cancer is, for much of its course, quiet. It doesn't announce itself. By the time it does, with a persistent cough, unexplained weight loss, breathlessness that won't go away, it has often already spread somewhere it shouldn't be.

That's not inevitable. It's exactly the problem that lung cancer screening is designed to address.

It has genuine, evidence-backed benefits for the right people. It can catch disease at a stage where treatment is more straightforward, and outcomes are meaningfully better. But it's widely underused, often misunderstood, and not particularly well explained.

This is a practical walkthrough for those who need more understanding: What the process actually involves, who it's for, what the results mean, and what to do with them.

Why Lung Cancer Screening Exists

Lung cancer has a particular problem that other commonly screened cancers don't have quite so severely: the early stages are usually silent.

With breast cancer, there's something to feel for. With bowel cancer, there are symptoms that, if you know what to look for, prompt investigation. With lung cancer, a tumour can grow for months, sometimes longer, without producing a single noticeable symptom.

The result is that a significant proportion of lung cancer diagnoses arrive at a stage where the options are limited. Not because the cancer couldn't have been treated earlier. Because earlier, no one knew it was there.

The process changes that equation. A low-dose CT scan can detect small abnormalities in lung tissue long before they become symptomatic. The evidence from large trials is clear: in people at higher risk, regular checkups reduce the likelihood of dying from lung cancer. That's a meaningful statement. It's not based on theory. It's based on data from tens of thousands of patients.

The important word in all of that is "higher risk." Screening isn't a universal recommendation. It's a targeted tool, and understanding who it's genuinely useful for matters. A consultation with an oncologist should be able to answer your questions about the importance of the procedure.

Who Should Be Screened?

The criteria for lung cancer screening eligibility generally come down to age and smoking history.

The typical eligibility window is roughly 55 to 74 years of age, combined with a significant smoking history, usually defined as 20 pack-years or more. A pack-year is one pack of cigarettes per day for one year, so 20 pack-years could mean 20 cigarettes a day for 20 years, or 40 a day for 10 years. Current smokers are included, as are former smokers who quit within the last 15 years or so.

Why these specific thresholds? Because the benefit needs to outweigh the risks. Screening sensitive enough to pick up early cancers will also pick up things that aren't cancer, and that leads to further tests, some of which carry their own small risks. In a low-risk population, the balance tips the wrong way. In a high-risk population, it tips clearly in favour.

For people who don't fit neatly into those criteria but have other reasons for concern, such as a strong family history of lung cancer, significant occupational exposure to substances like asbestos or radon, or a previous lung condition, it's worth a direct conversation with a specialist rather than assuming you don't qualify. The standard criteria are a guide, not a rigid gate.

One thing that's also worth saying: if you have symptoms like a cough that's been there for more than three weeks, coughing up blood, recurring chest infections, unexplained breathlessness or weight loss, don't wait for an invitation. Those symptoms need prompt clinical assessment, not a routine visit to the physician.

The Scan Itself: What Actually Happens

The test is a low-dose CT scan, often abbreviated to LDCT. Not a chest X-ray. That distinction matters: plain chest X-rays don't have the resolution to reliably detect early-stage lung cancer, which is why they've never been validated as a tool in the way LDCT has.

The scan itself is quick. The whole appointment usually takes around 30 minutes. The scan portion takes only a few minutes.

You'll lie flat on a narrow table that slides into a large, doughnut-shaped scanner. At certain points, you'll be asked to hold your breath briefly, usually for around five to ten seconds, while the machine captures images of your chest. That's it. No injection, no contrast dye in the standard screening version of the scan. You can drive yourself home afterwards. There's no recovery time.

The radiation dose is low, considerably lower than a standard diagnostic CT scan. It's not zero, and it's worth knowing that, but the dose is considered well within acceptable limits when weighed against the potential benefit for people who are genuinely at higher risk.

The images are then reviewed by a radiologist, often with support from computer-assisted analysis that can flag areas of interest for closer attention.

What the Scan Is Looking For

The main thing a lung cancer screening CT is looking for is pulmonary nodules, which are small, rounded areas of denser tissue within the lung.

The word "nodule" tends to alarm people. It shouldn't, at least not reflexively. The majority of nodules found on scans are benign. They're often remnants of old infections, small areas of scarring, or other minor changes that have nothing to do with cancer and never will.

What matters is the characteristics of the nodule: its size, shape, density, whether it has well-defined or irregular edges, and how it behaves over time.

You may come across two terms in your scan report. Solid nodules are dense throughout. Ground-glass opacities are hazier, less dense areas that look, as the name suggests, a bit like frosted glass on the scan image. Both can be benign. Both can, in specific circumstances, warrant further attention. Neither is automatically a diagnosis of anything.

The important thing to say here is that the test is sensitive by design. A sensitive test will sometimes find things that need follow-up but ultimately turn out to be nothing. That's not a flaw in the process. It's the trade-off that comes with catching cancer early. Understanding that in advance makes the follow-up process considerably easier to sit with.

Understanding Your Results

Results are typically communicated within a few weeks of the scan, often by letter.

Results are usually categorised by level of concern, ranging from nothing significant found to something that needs prompt further investigation.

If the scan is clear: No significant nodules were found. This is good news, but it doesn't mean zero ongoing risk. Doing the scan annually is usually recommended for people who remain within the eligible risk group. Lung cancer can develop in the interval between scans, which is why this isn't a one-time test.

If something was found: This is where I'd ask you to resist the immediate worst-case interpretation.

A finding on a scan most commonly leads to a recommendation for monitoring, often a follow-up scan in three to six months to see whether anything has changed. Small nodules that remain stable over time are almost always benign. This waiting period is genuinely difficult, and I don't want to be dismissive about that. But a surveillance recommendation is a precaution, not a diagnosis.

Larger nodules, or those with features that raise more concern, will be investigated more promptly.

If Something Needs Further Investigation

Further investigation typically follows one of a few paths.

More detailed imaging. A standard-dose CT scan with contrast dye, or a PET scan, can provide a clearer picture of whether a nodule has features consistent with cancer and whether there are signs of spread elsewhere.

Biopsy. If a nodule looks suspicious, a tissue sample is needed to confirm whether cancer cells are present. How that biopsy is performed depends on where in the lung the nodule is. Options include a bronchoscopy (a camera passed down into the airways), a CT-guided needle biopsy (a needle guided to the nodule through the chest wall using scan images), or occasionally a small surgical procedure. None of these is trivial, but they're all well-established and routinely performed.

Referral to a lung specialist. If you haven't already been referred, this is the point at which you should be. A lung cancer specialist can review the full picture, the imaging, the biopsy results if available, your history, and give you an honest assessment of what's going on and what the options are.

Timelines at this stage matter. If there's genuine clinical concern, investigations should move promptly. If you feel that things are moving more slowly than they should, it's completely reasonable to ask why. Private pathways can typically offer faster access to specialist review and more joined-up follow-up than a fragmented referral route.

The Limitations of Screening: What It Can and Can't Do

Screening is the best tool we have for catching lung cancer early in high-risk individuals. I believe that. But it's also imperfect, and I'd rather be straight about that than oversell it.

False positives are the most common issue. A finding that turns out to be benign after further investigation is a false positive. It causes anxiety, and it can lead to further tests that carry their own small risks.

False negatives are less common but possible. A very small or unusually located cancer can occasionally be missed.

Interval cancers do occur. These are cancers that develop and become symptomatic in the period between annual scans.

Overdiagnosis is perhaps the most complicated issue to explain. A small proportion of detected abnormalities may represent very slow-growing changes that would never have caused problems in a person's lifetime. Treating them carries its own risks and burdens. This is a genuine tension, and honest specialists acknowledge it. It doesn't mean screening isn't worthwhile. It means the decision to screen should involve a proper discussion of benefits and risks, not just a blanket recommendation.

Screening and Smoking Cessation

I'm going to say this once, and I'll try not to make it a lecture.

Screening is not a reason to carry on smoking.

There's evidence that going through a lung cancer assessment, even when the result is clear, can be a meaningful trigger for stopping. It makes the abstract risk feel real in a way that general health advice often doesn't. That's a genuine opportunity, and it's worth taking seriously.

Support for stopping smoking should be part of any programme worth its name. If it isn't offered alongside your screening, ask for it. The two things go together.

What to Do Before Your Scan

There's no complex preparation for a lung cancer screening CT.

Wear comfortable clothing. You'll be asked to remove anything with metal around the chest area. No need to fast beforehand. Bring any previous chest imaging you may have. Tell the team about any known lung conditions, previous lung surgery, or nodules that have already been identified.

Ask, when you book, how quickly results will be communicated and through what route. Knowing what the timeline looks like in advance takes one source of uncertainty off the table.

Questions Worth Asking

Whether you're considering screening or have already had your first scan, these are the conversations worth having:

• "Am I genuinely in the right risk group to benefit from screening?"
• "How often should I be scanned, and what would change that frequency?"
• "Who reviews the scans, and how experienced are they with lung imaging specifically?"
• "If something is found, what does the follow-up process look like, and how quickly does it move?"
• "At what point would I be referred directly to a lung specialist?"

A private screening pathway, done properly, means specialist involvement from the start rather than after a referral chain. That's not a small difference when time matters.

To Sum Up

Lung cancer screening saves lives. Not in a vague, theoretical way. In a measurable, documented way, in people who fit the criteria and follow through with the process.

The single most useful thing most high-risk people can do is ask whether they're eligible, rather than assuming someone will bring it up, or that the criteria don't apply to them.

If you're in the right age range, have a significant smoking history, and haven't been screened, it's worth having that conversation. If you've already been screened and something was found, getting to the right specialist quickly is what matters next.

That's a conversation I'm here to have.

About Dr James Wilson

Questions about cancer screenings often lead to wider discussions about cancer risk, diagnosis, and treatment. Dr James Wilson is a consultant clinical oncologist in private practice in London with expertise in melanoma and skin cancer treatment. He helps patients understand cancer, how it’s screened, the treatment options, and provides personalised guidance tailored to their individual circumstances.